Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.
Identifieur interne : 004C04 ( Ncbi/Curation ); précédent : 004C03; suivant : 004C05Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.
Auteurs : A. Palache [Pays-Bas] ; A. Abelin [France] ; R. Hollingsworth [France] ; W. Cracknell [Australie] ; C. Jacobs [Belgique] ; T. Tsai [États-Unis] ; P. Barbosa [Suisse]Source :
- Vaccine [ 1873-2518 ] ; 2017.
Abstract
There is no global monitoring system for influenza vaccination coverage, making it difficult to assess progress towards the 2003 World Health Assembly (WHA) vaccination coverage target. In 2008, the IFPMA Influenza Vaccine Supply International Task Force (IVS) developed a survey method to assess the global distribution of influenza vaccine doses as a proxy for vaccination coverage rates. The latest dose distribution data for 2014 and 2015 was used to update previous analyses. Data were confidentially collected and aggregated by the IFPMA Secretariat, and combined with previous IFPMA IVS survey data (2004-2013). Data were available from 201 countries over the 2004-2015 period. A "hurdle" rate was defined as the number of doses required to reach 15.9% of the population in 2008. Overall, the number of distributed doses progressively increased between 2004 and 2011, driven by a 150% increase in AMRO, then plateaued. One percent fewer doses were distributed in 2015 than in 2011. Twenty-three countries were above the hurdle rate in 2015, compared to 15 in 2004, but distribution was highly uneven in and across all WHO regions. Three WHO regions (AMRO, EURO and WPRO) accounted for about 95% of doses distributed. But in EURO and WPRO, distribution rates in 2015 were only marginally higher than in 2004, and in EURO there was an overall downward trend in dose distribution. The vast majority of countries cannot meet the 2003WHA coverage targets and are inadequately prepared for a global influenza pandemic. With only 5% of influenza vaccine doses being distributed to 50% of the world's population, there is urgency to redress the gross inequities in disease prevention and in pandemic preparedness. The 2003WHA resolution must be reviewed and revised and a call issued for the renewed commitment of Member States to influenza vaccination coverage targets.
DOI: 10.1016/j.vaccine.2017.07.053
PubMed: 28754488
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000808
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000805
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000805
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :004C04
Links to Exploration step
pubmed:28754488Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.</title>
<author><name sortKey="Palache, A" sort="Palache, A" uniqKey="Palache A" first="A" last="Palache">A. Palache</name>
<affiliation wicri:level="1"><nlm:affiliation>Consultant at Abbott, C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands. Electronic address: Bram.Palache@ziggo.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Consultant at Abbott, C.J. van Houtenlaan 36, 1381 CP Weesp</wicri:regionArea>
<wicri:noRegion>1381 CP Weesp</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Abelin, A" sort="Abelin, A" uniqKey="Abelin A" first="A" last="Abelin">A. Abelin</name>
<affiliation wicri:level="1"><nlm:affiliation>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007</wicri:regionArea>
<wicri:noRegion>69007</wicri:noRegion>
<placeName><settlement type="city">Lyon</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hollingsworth, R" sort="Hollingsworth, R" uniqKey="Hollingsworth R" first="R" last="Hollingsworth">R. Hollingsworth</name>
<affiliation wicri:level="1"><nlm:affiliation>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007</wicri:regionArea>
<wicri:noRegion>69007</wicri:noRegion>
<placeName><settlement type="city">Lyon</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cracknell, W" sort="Cracknell, W" uniqKey="Cracknell W" first="W" last="Cracknell">W. Cracknell</name>
<affiliation wicri:level="1"><nlm:affiliation>Seqirus, 63 Poplar Road, Parkville, Victoria 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Seqirus, 63 Poplar Road, Parkville, Victoria 3052</wicri:regionArea>
<wicri:noRegion>Victoria 3052</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jacobs, C" sort="Jacobs, C" uniqKey="Jacobs C" first="C" last="Jacobs">C. Jacobs</name>
<affiliation wicri:level="3"><nlm:affiliation>GSK Vaccines, Avenue Fleming 20, 1300 Wavre, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>GSK Vaccines, Avenue Fleming 20, 1300 Wavre</wicri:regionArea>
<placeName><region type="land" nuts="2">Vienne (Autriche)</region>
<settlement type="city">Vienne (Autriche)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tsai, T" sort="Tsai, T" uniqKey="Tsai T" first="T" last="Tsai">T. Tsai</name>
<affiliation wicri:level="2"><nlm:affiliation>Takeda Vaccines, 40 Landsdowne Street, Cambridge, MA 02139, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Takeda Vaccines, 40 Landsdowne Street, Cambridge, MA 02139</wicri:regionArea>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Barbosa, P" sort="Barbosa, P" uniqKey="Barbosa P" first="P" last="Barbosa">P. Barbosa</name>
<affiliation wicri:level="1"><nlm:affiliation>International Federation of Pharmaceutical Manufacturers and Associations, Ch. des Mines 9, P.O. Box 195, 1211 Geneva 20, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>International Federation of Pharmaceutical Manufacturers and Associations, Ch. des Mines 9, P.O. Box 195, 1211 Geneva 20</wicri:regionArea>
<wicri:noRegion>1211 Geneva 20</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28754488</idno>
<idno type="pmid">28754488</idno>
<idno type="doi">10.1016/j.vaccine.2017.07.053</idno>
<idno type="wicri:Area/PubMed/Corpus">000808</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000808</idno>
<idno type="wicri:Area/PubMed/Curation">000805</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000805</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000805</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000805</idno>
<idno type="wicri:Area/Ncbi/Merge">004C04</idno>
<idno type="wicri:Area/Ncbi/Curation">004C04</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.</title>
<author><name sortKey="Palache, A" sort="Palache, A" uniqKey="Palache A" first="A" last="Palache">A. Palache</name>
<affiliation wicri:level="1"><nlm:affiliation>Consultant at Abbott, C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands. Electronic address: Bram.Palache@ziggo.nl.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Consultant at Abbott, C.J. van Houtenlaan 36, 1381 CP Weesp</wicri:regionArea>
<wicri:noRegion>1381 CP Weesp</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Abelin, A" sort="Abelin, A" uniqKey="Abelin A" first="A" last="Abelin">A. Abelin</name>
<affiliation wicri:level="1"><nlm:affiliation>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007</wicri:regionArea>
<wicri:noRegion>69007</wicri:noRegion>
<placeName><settlement type="city">Lyon</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hollingsworth, R" sort="Hollingsworth, R" uniqKey="Hollingsworth R" first="R" last="Hollingsworth">R. Hollingsworth</name>
<affiliation wicri:level="1"><nlm:affiliation>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007</wicri:regionArea>
<wicri:noRegion>69007</wicri:noRegion>
<placeName><settlement type="city">Lyon</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cracknell, W" sort="Cracknell, W" uniqKey="Cracknell W" first="W" last="Cracknell">W. Cracknell</name>
<affiliation wicri:level="1"><nlm:affiliation>Seqirus, 63 Poplar Road, Parkville, Victoria 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Seqirus, 63 Poplar Road, Parkville, Victoria 3052</wicri:regionArea>
<wicri:noRegion>Victoria 3052</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jacobs, C" sort="Jacobs, C" uniqKey="Jacobs C" first="C" last="Jacobs">C. Jacobs</name>
<affiliation wicri:level="3"><nlm:affiliation>GSK Vaccines, Avenue Fleming 20, 1300 Wavre, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>GSK Vaccines, Avenue Fleming 20, 1300 Wavre</wicri:regionArea>
<placeName><region type="land" nuts="2">Vienne (Autriche)</region>
<settlement type="city">Vienne (Autriche)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tsai, T" sort="Tsai, T" uniqKey="Tsai T" first="T" last="Tsai">T. Tsai</name>
<affiliation wicri:level="2"><nlm:affiliation>Takeda Vaccines, 40 Landsdowne Street, Cambridge, MA 02139, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Takeda Vaccines, 40 Landsdowne Street, Cambridge, MA 02139</wicri:regionArea>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Barbosa, P" sort="Barbosa, P" uniqKey="Barbosa P" first="P" last="Barbosa">P. Barbosa</name>
<affiliation wicri:level="1"><nlm:affiliation>International Federation of Pharmaceutical Manufacturers and Associations, Ch. des Mines 9, P.O. Box 195, 1211 Geneva 20, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>International Federation of Pharmaceutical Manufacturers and Associations, Ch. des Mines 9, P.O. Box 195, 1211 Geneva 20</wicri:regionArea>
<wicri:noRegion>1211 Geneva 20</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Vaccine</title>
<idno type="eISSN">1873-2518</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">There is no global monitoring system for influenza vaccination coverage, making it difficult to assess progress towards the 2003 World Health Assembly (WHA) vaccination coverage target. In 2008, the IFPMA Influenza Vaccine Supply International Task Force (IVS) developed a survey method to assess the global distribution of influenza vaccine doses as a proxy for vaccination coverage rates. The latest dose distribution data for 2014 and 2015 was used to update previous analyses. Data were confidentially collected and aggregated by the IFPMA Secretariat, and combined with previous IFPMA IVS survey data (2004-2013). Data were available from 201 countries over the 2004-2015 period. A "hurdle" rate was defined as the number of doses required to reach 15.9% of the population in 2008. Overall, the number of distributed doses progressively increased between 2004 and 2011, driven by a 150% increase in AMRO, then plateaued. One percent fewer doses were distributed in 2015 than in 2011. Twenty-three countries were above the hurdle rate in 2015, compared to 15 in 2004, but distribution was highly uneven in and across all WHO regions. Three WHO regions (AMRO, EURO and WPRO) accounted for about 95% of doses distributed. But in EURO and WPRO, distribution rates in 2015 were only marginally higher than in 2004, and in EURO there was an overall downward trend in dose distribution. The vast majority of countries cannot meet the 2003WHA coverage targets and are inadequately prepared for a global influenza pandemic. With only 5% of influenza vaccine doses being distributed to 50% of the world's population, there is urgency to redress the gross inequities in disease prevention and in pandemic preparedness. The 2003WHA resolution must be reviewed and revised and a call issued for the renewed commitment of Member States to influenza vaccination coverage targets.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C04 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 004C04 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:28754488 |texte= Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:28754488" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |